These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 12192542)

  • 21. Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
    Reinhardt MJ; Biermann K; Wissmeyer M; Juengling FD; Brockmann H; von Mallek D; Ezziddin S; Joe AY; Krause TM
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):608-12. PubMed ID: 16541268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
    Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
    J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
    Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
    Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as "trapping only" nodule at 99mTcO4- scintigraphy.
    dell'Erba L; Gerundini P; Caputo M; Bagnasco M
    J Endocrinol Invest; 2003 Nov; 26(11):1124-7. PubMed ID: 15008253
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
    Hod N; Strauss S; Horne T
    Harefuah; 2001 May; 140(5):421-4. PubMed ID: 11419067
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiopathologic atlas of thyroid scintigraphy.
    Gupta V
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):583-90. PubMed ID: 18604100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
    Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of 123iodine scintigraphy and perchlorate discharge test in the diagnosis of congenital hypothyroidism.
    Meller J; Zappel H; Conrad M; Roth C; Emrich D; Becker W
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():24-7. PubMed ID: 9439910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls.
    Smith JR; Oates E
    Clin Nucl Med; 2004 Mar; 29(3):181-93. PubMed ID: 15162989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroid scintigraphy].
    Secades I; Torres M; Arnáiz F; Castell M; La Banda JP
    Rev Esp Med Nucl; 1999 Jun; 18(3):227-30. PubMed ID: 10475736
    [No Abstract]   [Full Text] [Related]  

  • 32. EVALUATION OF QUANTITATIVE THYROID SCINTIGRAPHY FOR DIAGNOSIS AND STAGING OF DISEASE SEVERITY IN CATS WITH HYPERTHYROIDISM: COMPARISON OF THE PERCENT THYROIDAL UPTAKE OF PERTECHNETATE TO THYROID-TO-SALIVARY RATIO AND THYROID-TO-BACKGROUND RATIOS.
    Peterson ME; Guterl JN; Rishniw M; Broome MR
    Vet Radiol Ultrasound; 2016 Jul; 57(4):427-40. PubMed ID: 27062212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nuclear medicine diagnosis of the thyroid].
    Moser E
    Radiologe; 1989 Mar; 29(3):103-8. PubMed ID: 2540508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hemiagenesis.
    Sari O; Ciftçi I; Törü M; Erbaş B
    Clin Nucl Med; 2000 Oct; 25(10):766-8. PubMed ID: 11043712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular radiotheragnostics in thyroid disease.
    Singh N; Lewington V
    Clin Med (Lond); 2017 Oct; 17(5):453-457. PubMed ID: 28974598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthyroidism with or without pyramidal lobe Graves' disease or disseminated autonomously functioning thyroid tissue?
    Wahl R; Müh U; Kallee E
    Clin Nucl Med; 1997 Jul; 22(7):451-8. PubMed ID: 9227866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An uncommon case of Marine-Lenhart syndrome.
    Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioisotopic evaluation of the thyroid and the parathyroids.
    Price DC
    Radiol Clin North Am; 1993 Sep; 31(5):991-1015. PubMed ID: 8362060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change of 99m technetium-pertechnetate uptake by the thyroid under suppression (TcTus) induced by optimization of iodine supply in Germany].
    Reinhardt MJ; Trupkovic T; Schumacher T; Krause TM; Oexle C; Moser E
    Nuklearmedizin; 1998; 37(6):202-7. PubMed ID: 9770714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.